摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

23-oxo-9,10-secocholesta-5(Z),7(E),10(19)-trien-1α,3β,25-triol

中文名称
——
中文别名
——
英文名称
23-oxo-9,10-secocholesta-5(Z),7(E),10(19)-trien-1α,3β,25-triol
英文别名
1,25-Dihydroxy-23-oxo-vitamin D3;(6R)-6-[(1R,3aS,4E,7aR)-4-[(2Z)-2-[(3S,5R)-3,5-dihydroxy-2-methylidenecyclohexylidene]ethylidene]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-1-yl]-2-hydroxy-2-methylheptan-4-one
23-oxo-9,10-secocholesta-5(Z),7(E),10(19)-trien-1α,3β,25-triol化学式
CAS
——
化学式
C27H42O4
mdl
——
分子量
430.628
InChiKey
QBJVXMITWJPQNF-LQPBFCBKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    31
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.74
  • 拓扑面积:
    77.8
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    (5E,7E,20S)-3β-(tert-butyldimethylsilyloxy)-20-(p-tolylsulfonyloxymethyl)-9,10-seco-5,7,10(19)-pregnatriene 在 咪唑 、 selenium(IV) oxide 、 N-甲基吲哚酮 、 四丙基高钌酸铵 、 甲烷磺酸二异丁基氢化铝三乙胺lithium hexamethyldisilazane 作用下, 以 四氢呋喃甲醇乙醚正己烷二氯甲烷二甲基亚砜N,N-二甲基甲酰胺甲苯 为溶剂, 反应 8.09h, 生成 23-oxo-9,10-secocholesta-5(Z),7(E),10(19)-trien-1α,3β,25-triol
    参考文献:
    名称:
    Synthesis and biological evaluations of C-23-modified 26,26,26,27,27,27-F 6 -vitamin D 3 analogues
    摘要:
    A convenient synthetic method which could allow flexible modification at C-23 of 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D-3 (3) has been developed. An effective construction of hexafluoroacetone (HFA) aldol part on the side chain of 10 was achieved by aldol reaction with HFA gas. This route is also attractive as an approach to diverse 26,27-modified vitamin D3 analogues. The preliminary biological activities of 23-modifed 26,27-F-6 vitamin D3 analogues are evaluated. The potency of VDR affinities of the C-23-substituted analogues (keto group (4); OH group (5a,5b); fluorine atom (6a,6b); and oxetane ring (7a,7b)) was found to vary depending upon both the nature and stereochemistry of the substituents. In contrast, the HL-60 cell differentiation property was less varied than VDR affinity, and depended upon the nature rather than the stereochemistry of the substituents. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0968-0896(00)00106-1
点击查看最新优质反应信息

文献信息

  • JPS58208228A
    申请人:——
    公开号:JPS58208228A
    公开(公告)日:1983-12-03
  • Synthesis and biological evaluations of C-23-modified 26,26,26,27,27,27-F 6 -vitamin D 3 analogues
    作者:Masahiko Ikeda、Haruki Matsumura、Nobuyuki Sawada、Katsuhiro Hashimoto、Tomoyuki Tanaka、Toshihiro Noguchi、Masaji Hayashi
    DOI:10.1016/s0968-0896(00)00106-1
    日期:2000.7
    A convenient synthetic method which could allow flexible modification at C-23 of 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D-3 (3) has been developed. An effective construction of hexafluoroacetone (HFA) aldol part on the side chain of 10 was achieved by aldol reaction with HFA gas. This route is also attractive as an approach to diverse 26,27-modified vitamin D3 analogues. The preliminary biological activities of 23-modifed 26,27-F-6 vitamin D3 analogues are evaluated. The potency of VDR affinities of the C-23-substituted analogues (keto group (4); OH group (5a,5b); fluorine atom (6a,6b); and oxetane ring (7a,7b)) was found to vary depending upon both the nature and stereochemistry of the substituents. In contrast, the HL-60 cell differentiation property was less varied than VDR affinity, and depended upon the nature rather than the stereochemistry of the substituents. (C) 2000 Elsevier Science Ltd. All rights reserved.
查看更多